|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-10-15
|
|
pubmed:abstractText |
Results of recently conducted prospective studies have demonstrated that the presence of high titers of anti-EBNA-1 or anti-EBNA complex IgG antibodies in healthy individuals is a strong risk factor for multiple sclerosis (MS). Antibodies to BZLF1, the product of the homonymous early lytic gene, have been found to be related to risk of nasopharyngeal carcinoma, but have not been previously measured in MS studies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-0208
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2007 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
214-5
|
|
pubmed:meshHeading |
pubmed-meshheading:17851260-Antibodies, Viral,
pubmed-meshheading:17851260-Case-Control Studies,
pubmed-meshheading:17851260-Cohort Studies,
pubmed-meshheading:17851260-DNA-Binding Proteins,
pubmed-meshheading:17851260-Female,
pubmed-meshheading:17851260-Herpesvirus 4, Human,
pubmed-meshheading:17851260-Humans,
pubmed-meshheading:17851260-Multiple Sclerosis,
pubmed-meshheading:17851260-Predictive Value of Tests,
pubmed-meshheading:17851260-Prospective Studies,
pubmed-meshheading:17851260-Risk Factors,
pubmed-meshheading:17851260-Trans-Activators,
pubmed-meshheading:17851260-Viral Proteins
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis.
|
|
pubmed:affiliation |
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. jmassa@hsph.harvard.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
